Health Risks: Efficacy Loss, Contamination, and Consistency Using expired compounded semaglutide poses three primary risks: reduced therapeutic efficacy (weakened weight-loss or glycemic benefits), increased contamination risk (bacterial growth or chemical byproducts), and dosing inconsistency (unmeasurable potency)
Keep a log of your dosages and any symptoms to share with your doctor
For sermorelin, common reactions include injection site irritation, headaches, dizziness, or flushing
Tumor antigen escape from CAR T-cell therapy
Early research suggests it may help improve blood sugar markers, particularly in people with metabolic concerns, but further evidence is required
Most doctors currently recommend injectable tirzepatide as the primary option because of its extensive clinical evidence